XIIDRA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 26 May 2022)
What this means for you
Registered since 27 Sept 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86056637
- Registration number
- 5050074
- Mark type
- Stylized text
- Filed
- 05 Sept 2013
- Published for opposition
- 21 Jan 2014
- Registered
- 27 Sept 2016
- Attorney of record
- Nancy L. Rowe
Goods and services
- Class 005 — Pharmaceuticals: Eye drops; pharmaceutical preparations for the treatment of dry eye syndrome
Owner
- BAUSCH + LOMB IRELAND LIMITED, DUBLIN, IE
- NOVARTIS AG, BASEL, CH
- SARcode Bioscience Inc., Lexington, MA, US
- SARcode Bioscience Inc., Brisbane, CA, US
- SARcode Bioscience Inc., Brisbane, CA, US
Prosecution history
- 27 Sept 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 01 Nov 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 25 Oct 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Oct 2023 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 25 Oct 2023 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 25 Oct 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Oct 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 May 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 26 May 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 26 May 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Dec 2021 — TEAS SECTION 8 & 15 RECEIVED
- 27 Sept 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 30 Oct 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 25 Oct 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Oct 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED